RBC Capital Maintains Outperform on Boston Scientific, Lowers Price Target to $52
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice TargetHot
RBC Capital analyst Kendall Au maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $70 to $52.
RBC Capital analyst Kendall Au maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $70 to $52.